References
- Baba, M., et al., 2020. Results of mirogabalin treatment for diabetic peripheral neuropathic pain in Asian subjects: a phase 2, double-blind, randomized, placebo-controlled, study. Pain and therapy, 9 (1), 261–278.
- Brown, K., et al., 2018. Tolerability, pharmacokinetics, and pharmacodynamics of mirogabalin in healthy subjects: Results from phase 1 studies. Pharmacology research & perspectives, 6 (5), e00418.
- Casadei, A.M., Galli, G., and Mandolini, L., 1984. Ring-closure reactions. 22. Kinetics of cyclization of diethyl (ω-bromoalkyl)malonates in the range of 4- to 21-membered rings. Role of ring strain. Journal of the American chemical society, 106 (4), 1051–1056.
- Domon, Y., et al., 2018. Binding characteristics and analgesic effects of mirogabalin, a novel ligand for the α2δ subunit of voltage-gated calcium channels. The journal of pharmacology and experimental therapeutics, 365 (3), 573–582.
- Jansen, M., et al., 2018. A randomised, placebo-controlled, double-blind study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and repeated dosed of mirogabalin in healthy Asian volunteers. Clinical pharmacology in drug development, 7 (6), 661–669.
- Kato, M., et al., 2018. Pharmacokinetics and safety of a single oral dose of mirogabalin in Japanease subjects with varying degrees of renal impairment. Journal of clinical pharmacology, 58 (1), 57–63.
- Kitano, Y., et al., 2019. [Pharmacological, pharmacodynamics, and clinical profile of mirogabalin besylate (Tarlige® tablets 2.5 mg·5 mg·10 mg·15 mg)] ). Nihon Yakurigaku Zasshi. Folia pharmacologica japonica, 154 (6), 352–361. [In Japanese with English abstract].
- Marais, E., Klugbauer, N., and Hofmann, F., 2001. Calcium channel alpha(2)delta subunits-structure and Gabapentin binding. Molecular pharmacology, 59 (5), 1243–1248.
- Orlando, R., et al., 1998. Determination of inulin clearance by bolus intravenous injection in healthy subjects and ascitic patients: equivalence of systemic and renal clearances of glomerular filtration markers. British journal of clinical pharmacology, 46, 605–609.
- Ruan, E.D., et al., 2013. Study of fragmentation behavior of amadori rearrangement products in lysine-containing peptide model by tandem mass spectrometry . European journal of mass spectrometry, 19 (4), 295–303.
- Vinik, A., et al., 2014. Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomised, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study. Diabetes care, 37 (12), 3253–3261.
- Zhong, S., et al., 2015. A new rapid in vitro assay for assessing reactivity of acyl Glucuronides. Drug metabolism and disposition: the biological fate of chemicals, 43 (11), 1711–1717.